# Peripheral Bypass Trial for Completion Control

> **NCT06264843** · — · RECRUITING · sponsor: **Medistim ASA** · enrollment: 450 (estimated)

## Conditions studied

- Chronic Limb-Threatening Ischemia

## Interventions

- **DEVICE:** MiraQ with Transit-Time Flow Measurement (TTFM) and L15 High Frequency Ultrasound (HFUS) probes

## Key facts

- **NCT ID:** NCT06264843
- **Lead sponsor:** Medistim ASA
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-14
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06264843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06264843, "Peripheral Bypass Trial for Completion Control". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06264843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*